Structure–Activity Relationships of Azaquinazolinone Derivatives as ¹⁸F‑Labeled PET Probes Targeting Ghrelin Receptors by Hiroyuki Watanabe (312793)

“…Among them, AQ-12 showed the highest binding affinity for GHSR. In a biodistribution study using normal mice, [¹⁸F]AQ-12 displayed high uptake in the pancreas, which is one of the GHSR-expressing organs, and its radioactivity was significantly decreased by coinjection with unlabeled AQ-12. …”

Baseline demographic characteristics. by Jung-Tae Kim (8997767)

“…Group 2 exhibited a significantly greater decrease in GCC thickness compared with Group 1(P = 0.026).…”

Flow diagram showing number of subjects included in the study population. by Jung-Tae Kim (8997767)

Temperature effects on populations of <i>S. haematobium</i> and <i>S. mansoni</i> infections. by Zadoki Tabo (12415261)

DDC for four anticoagulants from 2019 to 2023. by Wei Luo (80175)

“…</p><p>Results</p><p>From 2019 to 2023, the DDDs of rivaroxaban demonstrated a significant annual increase in most hospitals (<i>p</i> < 0.05). …”

Isotype control overlays. by Chen Lu (135200)

“…<div><p>Decompression sickness is a fatal disease worldwide. Therefore, to find a prophylactic modality for decompression sickness is urgently required. …”

Original uncropped blot. by Chen Lu (135200)

“…<div><p>Decompression sickness is a fatal disease worldwide. Therefore, to find a prophylactic modality for decompression sickness is urgently required. …”

Raw Data. by Chen Lu (135200)

“…<div><p>Decompression sickness is a fatal disease worldwide. Therefore, to find a prophylactic modality for decompression sickness is urgently required. …”

Identification of BM-MSCs. by Chen Lu (135200)

Inpatient utilization of anticoagulants from 2019 to 2023. by Wei Luo (80175)

Outpatient utilization of anticoagulants from 2019 to 2023. by Wei Luo (80175)

Utilization of anticoagulants from 2019 to 2023. by Wei Luo (80175)

The expenditure on anticoagulants in the period of 2019-2023(million CNY). by Wei Luo (80175)

Phosphate solubilizing microorganisms with clear halozone produced by, (A) Sw-T1, (B) Pu-T2, and (C) Pu-T4 isolates. by Riri Dayang Sari Risman (21696244)

Effects of BM-MSCs on different types of lung cell death in different group. by Chen Lu (135200)

Effects of BM-MSCs on ROS generation in DCS rats. by Chen Lu (135200)

Pretreatment of BM-MSCs improves the survival rate and incidence of DCS. by Chen Lu (135200)

Effect of BM-MSCs in improving DCS induced lung injury. by Chen Lu (135200)

Pretreatment of BM-MSCs attenuates DCS induced lung inflammation. by Chen Lu (135200)

Image 1_Investigating the potential immunomodulatory effects of commercial oral probiotic supplements on equine gastrointestinal tract barrier function.jpeg by Agnieszka Żak-Bochenek (20588453)

“…In all the cases, there was a gradual decrease in relative abundance over time. …”